A new study published in the Chest Journal showed that Full MIST2 dosing of intrapleural enzyme therapy (IET) was Linked to ...

Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.

A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion This is an ASCO Meeting Abstract from the 2006 ASCO ...

Malignant pleural mesothelioma (MPM) is a primary and locally aggressive tumor of the pleura. A well defined causal relationship with asbestos exposure, and an overwhelming media interest in the use ...

(MENAFN- GlobeNewsWire - Nasdaq) The global pleural effusion market is experiencing steady growth due to advancements in medical treatments and diagnostic tools, increased awareness of respiratory ...

Pleural diseases affect the pleural tissue that lines the inside of the chest cavity and covers the outside of the lungs. The visceral pleura (which covers the lung) and the parietal pleura (which ...

Empyema often co-occurs with pneumonia and refers to the presence of pus in the pleural space. There is a range of therapeutic options available for the management of empyema, the primary aim being to ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Pleural Effusion Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...